BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18936400)

  • 1. Multicentric reticulohistiocytosis successfully treated with infliximab: an illustrative case and evaluation of cytokine expression supporting anti-tumor necrosis factor therapy.
    Kalajian AH; Callen JP
    Arch Dermatol; 2008 Oct; 144(10):1360-6. PubMed ID: 18936400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric reticulohistiocytosis presenting with papulonodular skin eruption and polyarthritis.
    Baghestani S; Khosravi F; Dehghani Zahedani M; Mahboobi AA
    Eur J Dermatol; 2005; 15(3):196-200. PubMed ID: 15908308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab for the treatment of refractory progressive sterile peripheral ulcerative keratitis associated with late corneal perforation: 3-year follow-up.
    Odorcic S; Keystone EC; Ma JJ
    Cornea; 2009 Jan; 28(1):89-92. PubMed ID: 19092414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple cutaneous reticulohistiocytosis].
    Loche F; Lucas F; Bayle-Lebey P; Bazex J
    Ann Dermatol Venereol; 2000 May; 127(5):507-9. PubMed ID: 10863183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of multicentric reticulohistiocytosis with a combination of infliximab, prednisolone and methotrexate.
    Lee MW; Lee EY; Jeong YI; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2004; 84(6):478-9. PubMed ID: 15844643
    [No Abstract]   [Full Text] [Related]  

  • 6. Multicentric reticulohistiocytosis.
    Kaul A; Tolat SN; Belgaumkar V; Mhaske CB
    Indian J Dermatol Venereol Leprol; 2010; 76(4):404-7. PubMed ID: 20657124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients.
    Josselin L; Mahr A; Cohen P; Pagnoux C; Guaydier-Souquières G; Hayem G; Job-Deslandre C; Liferman F; Pourrat J; Guillevin L
    Ann Rheum Dis; 2008 Sep; 67(9):1343-6. PubMed ID: 18445626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthoma disseminatum with hepatic involvement in a child.
    Büyükavci M; Selimoglu A; Yildirim U; Ertekin V; Atasoy M
    Pediatr Dermatol; 2005; 22(6):550-3. PubMed ID: 16354260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab.
    True DG; Penmetcha M; Peckham SJ
    J Rheumatol; 2002 Jul; 29(7):1561-3. PubMed ID: 12136922
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of recalcitrant psoriasis with a combination of infliximab and hydroxyurea.
    Gach JE; Berth-Jones J
    J Dermatolog Treat; 2003 Dec; 14(4):226-8. PubMed ID: 14660269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe progressive erosive arthritis in multicentric reticulohistiocytosis: possible involvement of cytokines in synovial proliferation.
    Nakajima Y; Sato K; Morita H; Torikai S; Hidano A; Nishioka K; Kashiwazaki S
    J Rheumatol; 1992 Oct; 19(10):1643-6. PubMed ID: 1464883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
    Rosen T; Doherty C
    Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric reticulohistiocytosis with generalized systemic involvement.
    Liu YH; Fang K
    Clin Exp Dermatol; 2004 Jul; 29(4):373-6. PubMed ID: 15245533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric reticulohistiocytosis associated with rheumatoid arthritis.
    Hoshina D; Shimizu T; Abe R; Murata J; Tanaka K; Shimizu H
    Rheumatol Int; 2005 Sep; 25(7):553-4. PubMed ID: 15765219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate treatment of multicentric reticulohistiocytosis.
    Gourmelen O; Le Loët X; Fortier-Beaulieu M; Thomine E; Ledan G; Lauret P; Deshayes P
    J Rheumatol; 1991 Apr; 18(4):627-8. PubMed ID: 2066959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric reticulohistiocytosis with elevated cytokine serum levels.
    Bennàssar A; Mas A; Guilabert A; Julià M; Mascaró-Galy JM; Herrero C
    J Dermatol; 2011 Sep; 38(9):905-10. PubMed ID: 21658110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC; Werth VP
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.